Rate Video

EBMT 2018 | Endothelial dysfunction in transplant: defibrotide for VOD

Paul Richardson • 18 Mar 2018

General Defibrotide

Speaking at the 2018 European Society for Blood and Marrow Transplantation (EBMT) Annual Meeting in Lisbon, Portugal, Paul Richardson, MD, from the Dana-Farber Cancer Institute, Boston, MA, talks about the pooled analysis of the efficacy of defibrotide in adults with veno-occlusive disease (VOD).

Key updates on transplant for multiple myeloma at ASH 2020

Paul Richardson • 6 Dec 2020

The safety and efficacy of isatuximab for R/R myeloma: insights from ICARIA-MM, IKEMA & CANDOR

Paul Richardson • 11 Jun 2022

A multiple myeloma patient story - a discussion between Vivien de Gunzburg and Paul Richardson

Paul Richardson et al. • 28 Apr 2016

Long-term follow-up of the TOURMALINE-MM1 trial

Paul Richardson • 14 May 2022

Related Videos

Highlights from EHA: in-person discussions & exciting updates

Arnon Nagler • 12 Jun 2022

The importance of patient-reported outcomes in clinical trials & clinical practice

Anna Sureda • 12 Jun 2022

Phase Ib study of Orca-T in patients with advanced hematologic malignancies

Caspian Oliai • 12 Jun 2022

Insights into the role of patient groups

Natacha Bolaños • 12 Jun 2022